Mesenchymal Stem Cell Therapies Approved by Regulatory Agencies around the World
Cellular therapy has used mesenchymal stem cells (MSCs), which in cell culture are multipotent progenitors capable of producing a variety of cells limited to the mesoderm layer. There are two types of MSC sources: (1) adult MSCs, which are obtained from bone marrow, adipose tissue, peripheral blood,...
Main Authors: | Luis E. Fernández-Garza, Silvia A. Barrera-Barrera, Hugo A. Barrera-Saldaña |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/16/9/1334 |
Similar Items
-
Disease modification in osteoarthritis; pathways to drug approval
by: Jeffrey N. Katz, et al.
Published: (2020-06-01) -
Regulatory Clearance and Approval of Therapeutic Protocols of Transcranial Magnetic Stimulation for Psychiatric Disorders
by: Gonçalo Cotovio, et al.
Published: (2023-07-01) -
From Vial to Vein: Crucial Gaps in Mesenchymal Stromal Cell Clinical Trial Reporting
by: Danielle M. Wiese, et al.
Published: (2022-04-01) -
Mitigating Deficiencies in Evidence during Regulatory Assessments of Advanced Therapies: A Comparative Study with Other Biologicals
by: Magdi Elsallab, et al.
Published: (2020-09-01) -
Improving Interactions Between Health Technology Assessment Bodies and Regulatory Agencies: A Systematic Review and Cross-Sectional Survey on Processes, Progress, Outcomes, and Challenges
by: Richard Ofori-Asenso, et al.
Published: (2020-10-01)